Pharmaceutical products called on to be greener by MEPs: Further development of “greener” pharmaceuticals is being called for by Members of the European Parliament (MEPs) , which are less harmful to the environment, but as effective for patients.
Making products more biodegradable whilst not impairing their efficacy to tackle pharmaceutical pollution is being urged for in the EU.
MEPs are calling for the development of greener manufacturing and better waste management across the EU and say measures towards more “sensible use” and disposal of pharmaceuticals should be taken to prevent risks to the environment and public health.
Pharmaceutical products both harm ecosystems and reduce their future effectiveness stress the MEPs, for example, by causing antibiotic resistance.
Despite often low concentrations, there is a risk that patient health can be affected in the long term, because medicines can affect water bodies as they cannot be effectively filtered by wastewater treatment plants.
Of particular concern by MEPs are the endocrine-disrupting properties of many medicines that end up in the environment.
They are encouraging doctors and veterinarians to provide information on how to properly dispose of unused medicines and calling on member states to share best practices in limiting preventive use of antibiotics and in disposing of unused medicines.
The measures to reduce pollution they believe, should not only include end-of-pipe controls, for example, improved wastewater treatment, but encompass the entire lifecycle of drugs, from design and production to disposal.
Pharmaceutical products called on to be greener by MEPs